Events
In Cerebrospinal Fluid and the Identification of a Target Engagement Biomarker for the New Anti-Tau Antibody E2814 at Alzheimer’s Association International Conference (AAIC) 2019
Here’s a look at the top clinical trial news from last week, with updates from Neon, GSK, Biohaven, and more.
It was a big week for Alzheimer’s research as researchers from around the world descended on Los Angeles to attend the Alzheimer’s Association International Conference (AAIC) this week. Here’s a look at some of the stories you may have missed.
On July 16, 2019, tech entrepreneur Elon Musk presented his vision for high-bandwidth brain-machine interfaces to connect humans and computers with help from XVIVO Scientific Animation, a leading scientific and medical animation studio based in Connecticut
Without Significant Effects on Synaptic Function in Brain by Spinal Densitiy Evaluation at Effective Dose to Decrease Amyloid Beta Level in Cerebrospinal Fluid at Alzheimer’s Association International Conference (AAIC) 2019
Assertio Therapeutics, Inc. announced that it will release second quarter 2019 financial results on Wednesday, August 7, 2019, after the close of markets.
GeoVax Labs, Inc. announced that Senior Scientist, Mugdha Vasireddi, PhD, will deliver an oral presentation entitled, A Single Dose of MVA-Based Lassa Virus Vaccine Provides Complete Protection in a Mouse Lethal Challenge Model.
As the 2020 election heats up, candidates for president are unveiling their plans to lower prescription drug prices.
Although the American public, Congress and the Trump administration have pressed for meaningful legislation over drug pricing, time is running out this year.
Anti-Abeta vaccine demonstrates strong safety and preliminary immunogenicity results in subjects with Down syndrome
PRESS RELEASES